Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Euclid Systems To Submit Ortho-K Contact Lens PMA For Overnight Wear

This article was originally published in The Gray Sheet

Executive Summary

Euclid Systems will submit a premarket approval application for the nighttime use of orthokeratology rigid gas-permeable extended wear (Ortho-K) contact lenses immediately upon completion of clinical data analysis, expected imminently.

You may also be interested in...



KeraVision Intacs Are Permanent, But Can Be Removed, FDA Concludes

Labeling for KeraVision's Intacs intrastromal corneal ring segments for treatment of mild myopia includes language indicating the reversible nature of the procedure. FDA approved the firm's August premarket approval application April 9.

Orthokeratology Lens Labeling Should Note Visual Improvement - Panel

Companies submitting premarket approval applications for rigid gas-permeable, extended-wear contact lenses for overnight orthokeratology (Ortho-K) should include in labeling a data grid showing the expected eyesight improvement likely to result from the process, FDA's Ophthalmology Devices Panel concluded at a Feb. 12 meeting in Rockville, Maryland.

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel